Teva Pharmaceutical Indus (TEVA)

Add to Watchlists
Create an Alert
70.69 +0.63  +0.90% NYSE Aug 4, 20:00 Delayed 2m USD

Teva Pharmaceutical Indus Return on Equity (TTM):

10.97% for June 30, 2015

View 4,000+ financial data types

Browse...
View Full Chart

Teva Pharmaceutical Indus Return on Equity (TTM) Chart

Export Data
Save Image

Teva Pharmaceutical Indus Historical Return on Equity (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2015 10.97%
March 31, 2015 11.87%
Dec. 31, 2014 13.17%
Sept. 30, 2014 11.95%
June 30, 2014 11.44%
March 31, 2014 6.17%
Dec. 31, 2013 5.67%
Sept. 30, 2013 5.39%
June 30, 2013 1.86%
March 31, 2013 7.59%
Dec. 31, 2012 8.63%
Sept. 30, 2012 9.44%
June 30, 2012 13.72%
March 31, 2012 12.44%
Dec. 31, 2011 12.13%
Sept. 30, 2011 13.35%
June 30, 2011 14.39%
March 31, 2011 15.99%
Dec. 31, 2010 16.36%
Sept. 30, 2010 14.82%
June 30, 2010 13.32%
March 31, 2010 12.28%
Dec. 31, 2009 11.27%
Sept. 30, 2009 5.53%
June 30, 2009 5.74%
   
March 31, 2009 6.12%
Dec. 31, 2008 4.27%
Sept. 30, 2008 13.34%
June 30, 2008 13.06%
March 31, 2008 13.62%
Dec. 31, 2007 15.94%
Sept. 30, 2007 15.86%
June 30, 2007 17.46%
March 31, 2007 18.16%
Dec. 31, 2006 5.82%
Sept. 30, 2006 4.73%
June 30, 2006 0.71%
March 31, 2006 -3.12%
Dec. 31, 2005 19.42%
Sept. 30, 2005 19.62%
June 30, 2005 20.13%
March 31, 2005 20.73%
Dec. 31, 2004 7.35%
Sept. 30, 2004 6.11%
June 30, 2004 4.33%
March 31, 2004 4.42%
Dec. 31, 2003 29.55%
Sept. 30, 2003 31.89%
June 30, 2003 31.40%
March 31, 2003 27.23%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Advertisement

TEVA Return on Equity (TTM) Benchmarks

Companies
Pfizer 12.38%
Novartis 26.60%
Mylan 19.57%

TEVA Return on Equity (TTM) Range, Past 5 Years

Minimum 1.86% Jun 2013
Maximum 16.36% Dec 2010
Average 10.87%

TEVA Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("TEVA", "return_on_equity")
  • Last 5 data points: =YCS("TEVA", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.